Related references
Note: Only part of the references are listed.Improved Survival with Experience: A 10-Year Learning Curve in Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery
Natasha L. Leigh et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Predicting Aborted Hyperthermic Intraperitoneal Chemotherapy (AHIPEC) with Preoperative Tumor and Inflammatory Markers in Potentially Resectable Appendiceal Cancer Patients with Peritoneal Carcinomatosis
Ekaterina Baron et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
The impact of tumor board on cancer care: evidence from an umbrella review
Maria Lucia Specchia et al.
BMC HEALTH SERVICES RESEARCH (2020)
The Chicago Consensus on Peritoneal Surface Malignancies: Standards
ANNALS OF SURGICAL ONCOLOGY (2020)
Implementation of a preoperative multidisciplinary team approach for frail colorectal cancer patients: Influence on patient selection, prehabilitation and outcome
Ellen van der Vlies et al.
JOURNAL OF GERIATRIC ONCOLOGY (2020)
Assessment of the Surgical Workforce Pertaining to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the United States
Darryl Schuitevoerder et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Clinical and surgical outcomes of patients with peritoneal mesothelioma discussed at a monthly national multidisciplinary team video-conference meeting
A. Brandl et al.
BJS OPEN (2020)
Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin
Carlos A. Munoz-Zuluaga et al.
EJSO (2019)
Long-term survival outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy: Single-institutional experience with 1225 cases
Lee Shyang Kyang et al.
JOURNAL OF SURGICAL ONCOLOGY (2019)
Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up)
V Lavoue et al.
JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION (2019)
Nurse Practitioners and Physician Assistants in Acute and Critical Care: A Concise Review of the Literature and Data 2008-2018
Ruth M. Kleinpell et al.
CRITICAL CARE MEDICINE (2019)
Evaluation of cytoreductive surgery and HIPEC for peritoneal surface malignancies: analysis of 384 consecutive cases
Vignesh Narasimhan et al.
LANGENBECKS ARCHIVES OF SURGERY (2019)
Outcomes in Peritoneal Dissemination from Signet Ring Cell Carcinoma of the Appendix Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Carlos Munoz-Zuluaga et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Ninety-day post-operative morbidity and mortality using the National Cancer Institute's common terminology criteria for adverse events better describe post-operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Mohammad Alyami et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2018)
Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival
Vivek Verma et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Prior Surgical Score: An Analysis of the Prognostic Significance of an Initial Nondefinitive Surgical Intervention in Patients With Peritoneal Carcinomatosis of a Colorectal Origin Undergoing Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy
Bikram K. Paul et al.
DISEASES OF THE COLON & RECTUM (2018)
Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US
Cheng- Liao et al.
GYNECOLOGIC ONCOLOGY (2018)
Postoperative Complications Independently Predict Cancer-Related Survival in Peritoneal Malignancies
M. Haroon A. Choudry et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
An 18 year population-based study on site of origin and outcome of patients with peritoneal malignancy in Ireland
J. G. Solon et al.
EJSO (2017)
A Prognostic Model for Predicting Overall Survival in Patients with Peritoneal Surface Malignancy of an Appendiceal Origin Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Chukwuemeka Ihemelandu et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Physician extenders on surgical services: a systematic review
Jagdeep Johal et al.
CANADIAN JOURNAL OF SURGERY (2017)
Recommendations and consensus on the treatment of peritoneal metastases of colorectal origin: a systematic review of national and international guidelines
C. E. L. Klaver et al.
COLORECTAL DISEASE (2017)
Evaluation of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a community setting: A cost-utility analysis of a hospital's initial experience and reflections on the health care system
Samer A. Naffouje et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
What Made Hyperthermic Intraperitoneal Chemotherapy an Effective Curative Treatment for Peritoneal Surface Malignancy: A 25-Year Experience With 1,125 Procedures
Guillaume Passot et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy
B. Moran et al.
COLORECTAL DISEASE (2015)
Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA)
V. Milovanov et al.
EJSO (2015)
Institutional Learning Curve of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Malignancies
Patricio M. Polanco et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Morbidity, mortality, and oncological outcomes of 401 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC)
Mariangela Desantis et al.
LANGENBECKS ARCHIVES OF SURGERY (2015)
Melphalan: A Promising Agent in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Armando Sardi et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Cytoreductive surgery plus perioperative intraperitoneal chemotherapy in pseudomyxoma peritonei: Aspects of the learning curve
H. Andreasson et al.
EJSO (2014)
Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy: Experience with 1,000 Patients
Edward A. Levine et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2014)
Cytoreductive Surgery and HIPEC in the Baltic States: An International Scientific Workshop with Live Surgery
Eligijus Poskus et al.
(2014)
Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: Analysis of survival outcomes
A. Sardi et al.
EJSO (2013)
Outcomes of cytoreduction with hyperthermic intraperitoneal chemotherapy: our experience at a midwest community hospital
Brent Goslin et al.
AMERICAN JOURNAL OF SURGERY (2012)
Multidimensional Analysis of the Learning Curve for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Surface Malignancies
Shigeki Kusamura et al.
ANNALS OF SURGERY (2012)
The Role of Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy (CRS/HIPEC) in Patients with High-Grade Appendiceal Carcinoma and Extensive Peritoneal Carcinomatosis
Hatem El Halabi et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Neoplasms of the Appendix Current Treatment Guidelines
Suven Shankar et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2012)
The Development of a Peritoneal Surface Malignancy Program: a Tale of Three Hospitals
Umut Sarpel et al.
JOURNAL OF CANCER EDUCATION (2012)
The Importance of the Learning Curve and Surveillance of Surgical Performance in Peritoneal Surface Malignancy Programs
Shigeki Kusamura et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2012)
Morbidity and Mortality of 109 Consecutive Cytoreductive Procedures with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Performed at a Community Hospital
Alexander G. Kerscher et al.
WORLD JOURNAL OF SURGERY (2010)
Are Temporary Staff Associated with More Severe Emergency Department Medication Errors?
Julius Cuong Pham et al.
Journal for Healthcare Quality (2010)
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm
Dennis S. Chi et al.
GYNECOLOGIC ONCOLOGY (2009)
8-year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer
Vic J. Verwaal et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei)
Brendan Moran et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
Learning curve of combined modality treatment in peritoneal surface disease
R. M. Smeenk et al.
BRITISH JOURNAL OF SURGERY (2007)
Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy
PH Sugarbaker et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
D Dindo et al.
ANNALS OF SURGERY (2004)
Share Paper
